Jacques Cornet - Profound Medical Senior Sonalleve

PRN Stock  CAD 11.44  0.57  5.24%   

Executive

Jacques Cornet is Senior Sonalleve of Profound Medical Corp
Age 68
Address 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5
Phone647 476 1350
Webhttps://www.profoundmedical.com

Profound Medical Management Efficiency

The company has return on total asset (ROA) of (0.4462) % which means that it has lost $0.4462 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9017) %, meaning that it generated substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -0.69. In addition to that, Return On Capital Employed is likely to drop to -0.8. At this time, Profound Medical's Total Assets are very stable compared to the past year. As of the 30th of November 2024, Other Assets is likely to grow to about 4.4 M, while Non Current Assets Total are likely to drop about 1.9 M.
Profound Medical Corp has accumulated 7.94 M in total debt with debt to equity ratio (D/E) of 60.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Profound Medical Corp has a current ratio of 4.56, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Profound Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Profound Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Profound Medical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Profound to invest in growth at high rates of return. When we think about Profound Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Jonathan KanderkaGreenfire Resources
N/A
Marisa FabianoRogers Communications
N/A
Sebastian TallaridaAclara Resources
N/A
Charles EsqGreenfire Resources
N/A
Nicolangelo VecchiarelliCCL Industries
N/A
Patricio IrribarraAclara Resources
N/A
James SellorsCCL Industries
N/A
Darren CrawfordGreenfire Resources
N/A
Terrie TweddleRogers Communications
N/A
Mark KennedyRogers Communications
N/A
PMP PEAclara Resources
N/A
Anton CAGreenfire Resources
49
Lalitha VaidyanathanCCL Industries
N/A
Jonathan PEngGreenfire Resources
N/A
Kevin CETGreenfire Resources
59
Rodrigo CeballosAclara Resources
N/A
PEng MBAGreenfire Resources
48
Fernando IllanesAclara Resources
N/A
Albert PEngGreenfire Resources
42
Nelson DonosoAclara Resources
N/A
David IIIOrca Energy Group
83
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. PROFOUND MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 64 people. Profound Medical Corp (PRN) is traded on Toronto Exchange in Canada and employs 131 people. Profound Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Profound Medical Corp Leadership Team

Elected by the shareholders, the Profound Medical's board of directors comprises two types of representatives: Profound Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Profound. The board's role is to monitor Profound Medical's management team and ensure that shareholders' interests are well served. Profound Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Profound Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Arun MBA, Chairman CEO
Hartmut Warnken, Senior Alliances
Jacques Cornet, Senior Sonalleve
Stephen Kilmer, Investor Relations
Mathieu Burtnyk, Senior TULSAPRO
Thomas MBA, Chief Officer
Abbey Goodman, Chief Global
Levant Tinaz, Software Developer
Michael Mydra, VP Access
Rashed Dewan, Chief Officer

Profound Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Profound Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Profound Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.